Patterns of treatment with chemotherapy and monoclonal antibodies for metastatic colorectal cancer in Western Europe

Author： Zhao Zhongyun Pelletier Elise Barber Beth Bhosle Monali Wang Song Gao Sue Klingman David

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.28, Iss.2, 2012-02, pp. : 221-229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Variation in hospital treatment patterns for metastatic colorectal cancer

CANCER, Vol. 121, Iss. 11, 2015-06 ,pp. : 1755-1761

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatic Arterial Chemotherapy for Colorectal Cancer Metastatic to the Liver

Oncology, Vol. 59, Iss. 2, 2000-08 ,pp. : 89-97

Karger

Access to resources Recommend Favorite

Costs of chemotherapy in the treatment of colorectal cancer

By Jansman F. Postma M.

The European Journal of Health Economics, Vol. 7, Iss. 2, 2006-06 ,pp. : 145-146

Springer Publishing Company

Access to resources Recommend Favorite

FOLFOX-4 Stop and Go and Capecitabine Maintenance Chemotherapy in the Treatment of Metastatic Colorectal Cancer

Oncology, Vol. 70, Iss. 5, 2007-01 ,pp. : 345-350

Karger

Access to resources Recommend Favorite

Stop and Go FOLFOX plus Bevacizumab Chemotherapy in the First-Line Treatment of Metastatic Colorectal Cancer

Oncology, Vol. 79, Iss. 1-2, 2010-11 ,pp. : 67-71

Karger

Access to resources Recommend Favorite